Results 141 to 150 of about 1,682,836 (306)

When Fat Goes Astray: Your Liver and Pancreas Get Into Trouble

Portal Hypertension &Cirrhosis, EarlyView.
Metabolic dysfunction‐associated steatotic liver disease (MASLD) and intrapancreatic fat deposition (IPFD) are both common manifestations of ectopic fat accumulation. Although they share multiple risk factors, they also show notable differences in pathological features, standardization of diagnosis, and research maturity.
Yuying Chen, Li Ding, Shan Zhao, Weihong Wang, Jing Zhong, Qiang Yan   +5 more
wiley   +1 more source

Dendritic Cell Served as Salvage Therapy for Advanced Hepatocellular Carcinoma Resistant to Tyrosine Kinase or Immune Checkpoint Inhibitors. [PDF]

Cancers (Basel)
Lee WC, Wu TH, Cheng CH, Lai Y, Hung HC, Lee JC, Wang YC, Lee CF, Wu TJ, Chou HS, Chan KM.   +10 more
europepmc   +1 more source

Advances in Viral Markers for Predicting Functional Cure of Chronic Hepatitis B

Portal Hypertension &Cirrhosis, EarlyView.
Functional cure, defined as sustained hepatitis B surface antigen (HBsAg) loss, is achieved by only a minority of patients with chronic hepatitis B (CHB); early identification of likely responders may improve cure rates and reduce costs. However, responses to antiviral therapy vary considerably, necessitating reliable hepatitis B virus (HBV) viral ...
Xinrong Lu, Xin Yang, Qishui Ou, Zhen Xun   +3 more
wiley   +1 more source

HLA ANTIGENS IN HBsAg POSITIVE CHRONIC HEPATITIS

The Turkish Journal of Gastroenterology, 1993
Orhan ERBAŞ, Berrin Arısoy ESEN, Nilgün Sönmez ACAR, Jale SOYDİNÇ, Yaşar ACAR, Burhan ŞAHİN   +5 more
doaj  

Impact of oncogenic viruses on autoimmune diseases and tumorigenesis. [PDF]

Infect Agent Cancer
Hamidi Sofiani V, Khodadadpour Mahani F, Farsiu N, Yousefi M, Naderi M, Ahmadi G, Nakhaie M.   +6 more
europepmc   +1 more source

Detection and distribution of hepatitis C—specific antigens in naturally infected liver

Hepatology, 1994
K. Blight, R. Lesniewski, J. Labrooy, E. Gowans   +3 more
semanticscholar   +1 more source

Radiotherapy and Immunotherapy In Hepatocellular Carcinoma: Priming the Tumor Immune Microenvironment From Bench To Bedside

Precision Radiation Oncology, EarlyView.
The dual immunomodulatory network of radiotherapy in hepatocellular carcinoma. Radiotherapy initiates its effects by inducing immunogenic cell death and DNA double‐strand breaks. Immune Activation: Cytosolic DNA from damaged cells activates the cGAS‐STING pathway, triggering IRF3/NF‐κB‐mediated type I interferon production. This enhances dendritic cell
Zhigang Fu, Yang Zhang, Zuomin Wang, Zongjuan Li, Shisuo Du   +4 more
wiley   +1 more source

Serological Interference Related to Intravenous Immunoglobulins: A Case of False Immunization Against Hepatitis B Virus. [PDF]

Eur J Case Rep Intern Med
Fadili H, Smaali J, Snoussi M, Ousti F, Zrara A, El Bakkouri J.   +5 more
europepmc   +1 more source

HEPATITIS B ANTIGEN AND THE LIVER

Medicine, 1978
A A, Mihas, M E, Conrad
openaire   +2 more sources

Disease Progression Mathematical Modeling With a Case Study on Hepatitis B Virus Infection

CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 420-434, March 2025.
ABSTRACT Chronic Hepatitis B presents a significant health and socioeconomic burden. The risk of hepatocellular carcinoma remains elevated although treatments are available. Achieving an optimal treatment regimen necessitates a deep comprehension of the dynamic relationship between the virus and its host across disease states.
Clémence Boivin‐Champeaux, Nieves Velez de Mendizabal, Aksana Jones, Scott Balsitis, Stephan Schmidt, Justin S. Feigelman, Francine Johansson Azeredo   +6 more
wiley   +1 more source